Invention Grant
- Patent Title: Bilayer tablet formulations
- Patent Title (中): 双层片剂配方
-
Application No.: US13965879Application Date: 2013-08-13
-
Publication No.: US09050258B2Publication Date: 2015-06-09
- Inventor: Admassu Abebe , Kyle Martin , Jatin M. Patel , Divyakant Desai , Peter Timmins
- Applicant: AstraZeneca AB , AstraZeneca UK Limited
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Terence J. Bogie
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K31/155 ; A61K31/403 ; A61K31/70 ; A61K9/24 ; A61K31/7004 ; A61K31/7042 ; A61K45/06 ; A61K9/20
Abstract:
The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Public/Granted literature
- US20130330406A1 Bilayer Tablet Formulations Public/Granted day:2013-12-12
Information query
